Comments

Plus Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Plus Therapeutics (PSTV) operate in?

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PSTVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.6600

-0.06-8.97%

At close: -

$0.6585

-0.00150-0.23%

After Hours: 7:08 PM EDT

Plus Therapeutics (PSTV) Forecast

News Earnings Plus Therapeutics (PSTV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Plus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PSTV | Benzinga

Explore Plus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PSTV.

Open	$0.72
Close	$0.66
Volume / Avg.	285.40K / 71.47K
Day Range	$0.63 - $0.72
52 Wk Range	0.65 - 2.67
Market Cap	$3.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	1.03%
Days to Cover	2.18

Recent News

Dow Tumbles Over 200 Points; Carnival Posts Upbeat Earnings

Avi Kapoor

Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense

Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.72
Close	$0.66
Volume / Avg.	285.40K / 71.47K
Day Range	$0.63 - $0.72
52 Wk Range	0.65 - 2.67
Market Cap	$3.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	1.03%
Days to Cover	2.18

About Plus Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Plus Therapeutics (PSTV) stock?

You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.

View our list of the best stock brokerages

Who are Plus Therapeutics (PSTV) competitors?

Other companies in Plus Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Synaptogenix (NASDAQ:SNPX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the forecast, or price target, for Plus Therapeutics (PSTV) stock?

Plus Therapeutics has a consensus price target of $11.00.

What is the current price for Plus Therapeutics (PSTV)?

The stock price for Plus Therapeutics (NASDAQ: PSTV) is $0.6585 last updated March 3, 2025 at 7:08 PM EST.

Does Plus Therapeutics (PSTV) pay a dividend?

There are no upcoming dividends for Plus Therapeutics.

When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?

Plus Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is Plus Therapeutics (PSTV) going to split?

There is no upcoming split for Plus Therapeutics.

What sector and industry does Plus Therapeutics (PSTV) operate in?

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.